Analysis
Pharma companies are also increasingly turning to AI to accelerate research and development.
1
Small biotech firms quicker to 'latch onto' AI than big ones: Tencent's Alex Ng
2
Himalaya Wealth Managers launches SME fund, eyes $52m corpus
3
EQT, Google Cloud join hands for AI rollout
4
South Korean government-led fund to invest $533m in FuriosaAI
5
HDFC Capital ropes in Development Bank of Japan as LP for real estate PE fund
More Stories
Strategic exits to outpace IPOs in Vietnam’s F&B sector: Maestro Equity
Stablecoins’ second wave is hitting mainstream finance, as capital shifts to the rails
EQT veterans appointed as co-heads for Asia private equity business
India: Healthworld Hospitals ropes in Merfin Advisors to raise $25m amid Tier II push
Vietnam’s Pharmacity secures growth capital from LeapFrog Investments
Private Equity
The fund is targeting a gross IRR of over 20%.
Google engineers will work alongside EQT’s AI transformation team of about 35 people.
The firm has been valued at $2b in the latest round of funding.
H-DREAM has a target corpus of $500 million, with a greenshoe option of an additional $500 million.
Greater China
The Shanghai Futures Exchange is in the early stages of designing futures contracts for so-called AI tokens.
ByteDance currently sources CPUs from Intel and AMD.
The Fidelity China unit managed $663.10 million worth of assets as of the end of March.
Rest of Asia
The move comes two years after JIC took the firm private in a $6 billion deal.
Anthropic has roped in Sangeeta Bavi as the Head of Digital Natives, Startups and Growth for India.
